Workflow
Kimball Electronics(KE)
icon
Search documents
Kimball Electronics(KE) - 2020 Q4 - Annual Report
2020-08-27 21:03
UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-K (Mark One) x ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the fiscal year ended June 30, 2020 incorporation or organization) 1205 Kimball Boulevard, Jasper, Indiana 47546 (Address of principal executive of ices) (Zip Code) OR o TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to (State or other jurisdiction of (I. ...
Kimball Electronics(KE) - 2020 Q4 - Earnings Call Presentation
2020-08-19 18:01
Financial Results Fourth Quarter Fiscal Year 2020 Quarter Ended June 30, 2020 Supplementary Information to August 19, 2020 Earnings Conference Call KIMBALL ELECTRONICS (Nasdaq: KE) // Safe Harbor Statement Certain statements contained within this supplementary information and any statements made during our earnings conference call today may be considered forward-looking under the Private Securities Litigation Reform Act of 1995 and are subject to risks and uncertainties including, but not limited to, succes ...
Kimball Electronics(KE) - 2020 Q3 - Quarterly Report
2020-05-05 20:17
Financial Performance - For the nine months ended March 31, 2020, net sales increased by 6% to $914.4 million compared to $863.2 million for the same period in 2019[128]. - In the third quarter of fiscal year 2020, consolidated net sales decreased by 6% to $293.9 million from $313.5 million in the same quarter of fiscal year 2019[127]. - Gross profit for the third quarter of fiscal year 2020 was $20.2 million, representing 6.9% of net sales, down from $26.6 million or 8.5% of net sales in the prior year[127]. - Net income for the third quarter of fiscal year 2020 was $6.3 million, a decrease of 47% compared to $11.8 million in the same quarter of fiscal year 2019[127]. - The automotive segment experienced a year-to-date sales increase of 11% to $383.7 million, while the medical segment saw a 3% increase to $274.1 million[129]. - The company reported a diluted earnings per share of $0.25 for the third quarter of fiscal year 2020, down 46% from $0.46 in the same quarter of fiscal year 2019[127]. Orders and Demand - Open orders increased by 35% to $511.0 million as of March 31, 2020, compared to $379.5 million in the same period of the previous year[127]. - Sales to customers in the automotive market decreased in Q3 FY2020 compared to Q3 FY2019, largely due to lower demand and COVID-19 impacts, partially offset by electric vehicle programs and new product introductions[130]. - Open orders increased by 35% as of March 31, 2020, compared to March 31, 2019, driven by significant demand in the medical market related to respiratory care due to COVID-19[131]. - The company anticipates growth in sales to customers in the medical market due to increased demand for medical assemblies, particularly for respiratory care and patient monitoring products[157]. Financial Position - The company maintains a strong balance sheet with a current ratio of 2.1 and a debt-to-equity ratio of 0.3 as of March 31, 2020[121]. - The debt-to-equity ratio remained stable at 0.3 as of March 31, 2020, consistent with June 30, 2019[141]. - As of March 31, 2020, the company had $115.8 million in borrowings under the primary credit facility, with $91.5 million classified as long-term[154]. - As of March 31, 2020, the unused borrowings under all credit facilities totaled $64.1 million, indicating sufficient liquidity for working capital needs[158]. Cash Flow and Investments - Net cash provided by operating activities for the first nine months of FY2020 was $51.3 million, a significant improvement from a cash usage of $19.0 million in FY2019[145]. - The company invested $27.8 million in capital expenditures during the first nine months of FY2020, primarily for machinery and equipment[149]. - Capital expenditure commitments as of March 31, 2020, were approximately $2.2 million, primarily for capacity and replacement purposes[160]. - The company expects to increase capital investments in the upcoming quarters to expand capacities to meet increased demand for medical assemblies due to COVID-19[160]. - The company has repurchased $76.7 million of common stock under its stock repurchase plan through March 31, 2020, with a total authorized amount of $80 million[163]. Tax and Regulatory Matters - The effective tax rate for the first nine months of FY2020 was 25.8%, compared to 19.3% in FY2019, influenced by lower profit before tax and discrete adjustments[138]. - The remaining provision for the one-time deemed repatriation tax was $9.8 million as of March 31, 2020, expected to be paid with available liquidity[161]. Acquisitions and Integration - The company completed the acquisition of GES Holdings, Inc. on October 1, 2018, to enhance its capabilities in automation, test, and inspection equipment[119]. - Goodwill increased by $1.8 million due to purchase accounting adjustments associated with the GES acquisition[140]. - The GES acquisition completed on October 1, 2018, had a net adjusted purchase price of $42.4 million, including a working capital adjustment of $7.6 million[159]. Market Risks and Uncertainties - The company is actively monitoring the impact of COVID-19 on its operations, supply chain, and workforce availability, which poses significant uncertainties[116]. - The company acknowledges that forward-looking statements are subject to various risks and uncertainties, including integration of acquisitions and changes in global economic conditions[174]. - There were no material changes in the company's exposure to market risks related to foreign currency exchange rates and interest rates compared to the fiscal year ended June 30, 2019[175]. - The interest rate on certain borrowings is based on LIBOR, which may be affected by the discontinuation of LIBOR reporting after 2021[175]. - The company is actively monitoring developments regarding LIBOR and its potential impact on financial operations[175]. - Comprehensive disclosures regarding market risk can be found in the Annual Report on Form 10-K for the year ended June 30, 2019[176].
Kimball Electronics(KE) - 2020 Q2 - Quarterly Report
2020-02-06 21:22
UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-Q (Mark One) x QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended December 31, 2019 OR o TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission File Number 001-36454 KIMBALL ELECTRONICS, INC. (Exact name of registrant as specified in its charter) Indiana 35-2047713 incorporation or or ...
Kimball Electronics(KE) - 2020 Q1 - Quarterly Report
2019-11-06 21:21
UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-Q (Mark One) x QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended September 30, 2019 OR o TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission File Number 001-36454 KIMBALL ELECTRONICS, INC. (Exact name of registrant as specified in its charter) Indiana 35-2047713 (State or other ju ...
Kimball Electronics(KE) - 2019 Q4 - Annual Report
2019-08-27 20:49
UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-K (Mark One) x ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the fiscal year ended June 30, 2019 OR o TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission File Number 001-36454 KIMBALL ELECTRONICS, INC. (Exact name of registrant as specified in its charter) Indiana 35-2047713 (State or other jurisdiction of ...
Kimball Electronics(KE) - 2019 Q3 - Quarterly Report
2019-05-08 17:42
UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-Q (Mark One) x QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended March 31, 2019 OR o TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission File Number 001-36454 KIMBALL ELECTRONICS, INC. (Exact name of registrant as specified in its charter) Indiana 35-2047713 (State or other jurisd ...
Kimball Electronics(KE) - 2019 Q2 - Quarterly Report
2019-02-07 21:43
(Mark One) x QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-Q For the quarterly period ended December 31, 2018 OR o TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission File Number 001-36454 KIMBALL ELECTRONICS, INC. (Exact name of registrant as specified in its charter) Indiana 35-2047713 (State or other jur ...